Articles tagged with Covid 19 Vaccines
Researchers developed a new method to assess immune responses to specific antigens after mRNA SARS-CoV-2 vaccine administration, using B cell receptor repertoire analysis. This approach enables evaluation of post-vaccination responses in immunocompromised patients with high antibody titers.
A new study found that around one in five people with compromised immune systems have no COVID-19 antibodies after three or more vaccinations. The MELODY study identified specific groups at higher risk of not producing antibodies, highlighting the need for targeted interventions and booster vaccines.
Scientists have discovered that SARS-CoV-2 can infect cells using multiple entry points beyond ACE2, explaining its ability to jump between species. This finding highlights the need for continued monitoring of coronaviruses and their potential to cause future pandemics.
Researchers found that sequential vaccinations given in the same arm generated a stronger immune response than those administered in different arms. This is particularly true for cytotoxic CD8+ T cells and antibodies targeting the SARS-CoV-2 virus.
Researchers found that COVID-19 vaccination generates antibodies in pregnant people that cross the placenta and protect their newborns against severe COVID-19 disease. Booster doses also increase maternal and newborn immune defenses against COVID-19, supporting the use of vaccination during pregnancy.
Recent studies have found no link between COVID-19 vaccination and sudden cardiac arrest in athletes. However, a small decrease in VO2 Max has been observed after vaccination, which may be temporary and have minimal clinical relevance.
A third COVID-19 vaccination dose significantly improved antibody responses in transplant recipients, offering better protection against variants. However, cross-protection was only partial, highlighting the need for multiple vaccine doses to maintain immunity in this vulnerable population.
Pregnant individuals who received a full course of COVID-19 vaccination and a booster have the strongest immune protection from the disease. Boosting after previous infection increases antibody levels in both mothers and newborns, providing maximum possible protection to infants as SARS-CoV-2 evolves.
A new Northwestern Medicine study measures resilience in biomedical scientists during COVID-19, revealing that resiliency did not guarantee career advancement. The study found that women scientists faced greater household responsibilities and social pressure to advance their careers, leading to significant career setbacks.
A large study found that fully vaccinated individuals have lower concentrations of inflammatory markers than unvaccinated participants after symptomatic COVID-19 infection. This suggests that vaccination significantly reduces morbidity and mortality by reducing elevated levels of cytokines and chemokines.
A new adjuvanted intranasal vaccine has shown promise in protecting both young and old mice against SARS-CoV-2 infection. The vaccine combines an RNA-based molecule with a nanoemulsion, resulting in a strong immune response.
A study of 6.3 million US older adults found the Moderna mRNA-1273 vaccine associated with a slightly lower risk of several adverse events, possibly due to improved protection against COVID-19. Future research should consider frailty in assessing vaccine performance and formally disentangle differences in safety and effectiveness.
A large head-to-head comparison study of the Moderna and Pfizer-BioNTech vaccines found that the Moderna vaccine was associated with a slightly lower risk of adverse events for older adults. The study also showed that the Moderna vaccine was linked to a 4% lower risk of pulmonary embolism and a 15% lower risk of diagnosed COVID-19.
A study from the University of Gothenburg found that even vulnerable people with compromised immune systems achieved good antibody levels after three doses of COVID-19 mRNA vaccine. This is particularly significant for those at risk of severe Covid-19, as they showed catch-up antibody responses and high levels of hybrid immunity.
Researchers developed a novel vaccine against SARS-CoV-2 by selecting antigen variants with low binding affinity, resulting in higher neutralizing antibody concentrations. This design strategy may also improve vaccine efficacy for other coronaviruses and herpes viruses.
A study using wastewater metrics found accurate assessments of county SARS-CoV-2 incidence and may be the best metric for monitoring virus circulation. Home testing increases and vaccination treatment decrease disease acuity, making wastewater surveillance a reliable option.
A study analyzing wearable device data from over 190,000 users found that vaccinated individuals experience less severe COVID-19 symptoms and recover faster. Vaccination reduces the risk of severe disease, hospitalization, ICU admission, and death.
Researchers developed a bioinformatic tool that selects parts of proteins to elicit strong immune responses. This approach, grounded in immunological theory, was four times more efficient than current methods, suggesting better vaccine protection against diseases.
Researchers leveraged genomics, transcriptomics, proteomics, and metabolomics to understand COVID-19 virus structure and mechanism of action. Multi-omics approaches identified potential antiviral drugs and characteristics of pathogens, informing vaccine design and therapeutic development.
A significant fall in Covid-related hospitalisations and mortality among UK cancer patients was found following the vaccine rollout. The study, published in Scientific Reports, revealed that age was a greater predictor of mortality rates than the type of cancer.
A study of 538,000 deaths in Florida and Ohio between March 2020 and December 2021 found significant excess mortality among Republican voters compared to Democratic voters. The disparity suggests differences in vaccination attitudes and uptake may have influenced pandemic severity and trajectory.
A large study found that vaccination can prevent COVID-19 hospitalizations with 205 individuals needed to be vaccinated, while preventing ED visits requires fewer vaccinations. The study's findings provide valuable insights into the vaccine's effectiveness, especially in older populations.
Researchers at Western University have discovered a potential 'super molecule' called 5-OP-RU that can enhance the effectiveness of several vaccines for viral diseases. The molecule binds to a protein called MR1 before stimulating mucosa-associated invariant T (MAIT) cells, which are key players in fighting off infection.
A new study suggests that people's judgments of anti-vaxxers who die from COVID-19 are complex and influenced by political party affiliation and vaccination status. Researchers found that Democrats and vaccinated individuals were more likely to view anti-vaxxers as deserving worse outcomes, while Republicans and unvaccinated individual...
A new study found that rural areas experienced higher excess deaths during the second year of the pandemic, despite vaccines being widely available in urban areas. The study highlights the role of healthcare inequities, vaccine skepticism, and partisanship in exacerbating mortality rates in rural communities.
A team of medical leaders recommends a sustainably funded public-private partnership to combat misinformation, citing challenges faced by the TIOS-VY organization. The American College of Physicians calls for modernizing public health infrastructure, including increased funding and addressing disinformation, especially on social media.
A new study found that COVID-19 vaccines significantly reduced dementia-related deaths in long-term care and nursing homes, with a 77% decrease in the second year. However, deaths among those living at home did not decline as much, with only a 16% reduction.
Scientists have teamed up to improve drug delivery by designing more effective lipid nanoparticles. Their latest study documents how high-throughput workflows can produce and characterize LNPs at record speed, with neatly ordered structures leading to better silencing of faulty genes in human neurons.
Studies showed mRNA vaccines provided long-term immunity against severe COVID-19 outcomes in cancer patients. The study found waning immunity after up to 4 mRNA vaccine doses, highlighting the need for booster shots.
A survey of 2,000 German adults found that people with higher levels of empathy and cosmopolitanism are more likely to prioritize sharing vaccine supplies internationally. The study suggests that there is substantial public support for international vaccine solidarity when infection rates are at a modest level and falling.
A new Boston University study found that COVID vaccines likely do not affect menstrual cycle regularity, bleed length, or pain. Menstrual cycles increased by 1.1 days after a first dose and 1.3 days after a second, but these changes resolved within one to two cycles.
Researchers at University of Bristol found that Long Covid is not caused by an immune inflammatory reaction to COVID-19. Instead, persistent immune activation and inflammation may persist for months after COVID-19, correlating with severe disease. The study suggests a new direction for understanding and potentially treating this debili...
Research by the University of Southampton found that repeated COVID-19 vaccine doses increase immune response in blood cancer patients, generating higher-quality antibodies. Booster vaccinations are essential for maintaining protection against COVID-19 in immunocompromised individuals.
A new analysis found that COVID-19 vaccination significantly reduced income-related disparities in disease incidence between low- and high-income communities in Los Angeles. Vaccination efforts in underserved communities were crucial in reducing these disparities.
A prospective study of COVID-19 mRNA vaccines found progressively declining immune functions in individuals with chronic lymphocytic leukemia (CLL). The study, published in PLOS Medicine, showed that CLL patients experienced reduced antibody responses to the vaccines.
Researchers developed a biodegradable nanoparticle that reaches dendritic cells in mice with melanoma and colon cancer, activating an immune response. The nanoparticle improves survival rates for these cancers, with half of mice surviving long-term after treatment.
Researchers found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity, with higher levels of antibodies promoting neutralization. The study suggests targeting the S2 region for intranasal vaccines may increase nasal mucosal levels of IgA and viral neutralization.
Scientists at the University of Cambridge identified a signature in the blood that could predict how well an individual responds to vaccines. They found that those with higher levels of age-associated B cells are less effective after vaccination.
A study published in Management Science found that the UK's Covid vaccine mandate caused a 3-4% reduction in staffing in elderly care homes, equivalent to 14,000 to 19,000 employees. The policy led to an increase in reliance on agency workers and persisted even after the mandate was lifted.
Researchers found that patients with persistent symptoms of long COVID experienced sustained inflammation and abnormal immune responses. However, after receiving a vaccine dose 12-16 months post-infection, these markers recovered to levels comparable to healthy vaccinated individuals.
Researchers at the University of Queensland have uncovered the atomic structure of the Langya virus, a highly infectious virus with pandemic potential. The study aims to develop broad-spectrum human vaccines and treatments for Henipaviruses, which cause severe disease and have the potential to get out of control.
A Singapore study found that COVID-19 vaccination remained effective against Omicron BA.4/BA.5 and XBB infections in children and adolescents. Vaccination before the first infection provided the highest immunity, with protection levels reaching up to 85.3%.
A study of 17,000 people across eight African countries found a decline in vaccine confidence, particularly for COVID-19 vaccines. The drop in routine childhood vaccinations has led to six million fewer children receiving life-saving shots, putting decades of progress at risk.
The BCG vaccine, primarily developed to prevent tuberculosis, was found ineffective against COVID-19 in a large international trial involving nearly 4,000 healthcare workers. Researchers discovered that vaccination increased the risk of symptomatic disease during the first six months following enrolment.
A large and diverse group of young children receiving mRNA COVID-19 vaccines found no indications of serious side effects. The study analyzed medical records for 23 serious potential side effects and found no safety concern for seizures or other outcomes.
A study by University of Missouri researchers found similarities in COVID-19 mortality rates between certain US states and Canadian provinces, highlighting the importance of localized public health strategies. The findings suggest that factors such as population density, age, and socioeconomic conditions may have contributed to these s...
Researchers have developed a color-changing material that can detect when medications get too warm, with tunable melting points to track temperatures from -94 to +99 degrees Fahrenheit. This innovative system has the potential to reduce electronic waste and improve medical cold supply chains.
Researchers found that boosting vaccine use can reduce lockdown intensity and duration, but the relationship varies based on factors like disease severity and vaccination speed. The study suggests a nuanced approach to balancing lockdowns and vaccinations in future pandemics.
Researchers analyzed hospitalization and fatality rates of SARS-CoV-2 infection in England between May 2020 and March 2022. The study found that the mass vaccination campaign significantly reduced severe effects of the virus, with notable improvements after the emergence of Alpha, Delta, and Omicron variants.
A nationwide study of nearly 10,000 adults identifies 12 hallmarks of long COVID, including debilitating fatigue, loss of smell or taste, and gastrointestinal symptoms. The findings provide a new scoring system for clinicians to define and investigate treatments for patients with long COVID.
The Vaccine Adverse Event Reporting System (VAERS) collects reports of adverse events after vaccination, but public confusion about its nature and reports has increased. A new report recommends renaming the system to a clearer alternative and making additional changes to reduce misinterpretation.
A comprehensive multicontinental analysis found that COVID-19 vaccination reduced mortality by 22% among hospitalized and oxygen-dependent individuals. Vaccination was particularly beneficial for vulnerable groups, such as the elderly and those with pre-existing conditions.
A new review of published research finds that vaccine hesitancy among parents is a persistent issue, with concerns about childhood vaccines persisting over time. The study highlights significant disparities in vaccination rates across states and demographic groups, including lower rates among Black and Hispanic children.
A recent study published in JAMA Pediatrics monitored the safety of Pfizer-BioNTech COVID-19 vaccine in over 3 million children, identifying only rare cases of myocarditis or pericarditis, consistent with previous reports. The results provide additional evidence supporting the safety of COVID-19 vaccines in children ages 5 to 17.
A large case-control surveillance study of over 100,000 pregnancies found COVID-19 booster vaccination not associated with spontaneous abortion. The results support the safety of COVID-19 booster vaccination recommendations for pregnant populations.
A decision analytical model found that increased uptake of bivalent booster vaccination among eligible age groups decreased pediatric hospitalizations and school absenteeism. The benefits of booster campaigns for children may be substantial, suggesting a focus on younger populations is crucial.
Researchers analyzed data from over 100,000 pregnancies and found no association between COVID-19 booster vaccination and increased miscarriage risk. The study adds to the growing understanding of the safety of COVID-19 booster vaccinations during early pregnancy.
A survey study found that fewer than 1 in 10 vaccinated individuals received an incentive, with most reporting no change in their decision to get vaccinated. The study suggests that policy efforts to incentivize vaccination may be ineffective.
A recent study found that COVID-19 infection can lead to increased infarct growth and ongoing tissue consumption even after successful reperfusion through angiography. This suggests a potentially aggressive clinical course for patients with COVID-19 and large-vessel occlusion acute ischemic stroke.
A new study investigates lockdowns and vaccines' complementary or substitutive roles in mitigating COVID-19's effects. The researchers found that vaccinations should be relaxed after substantial vaccination rates, but vastly different policies may be optimal depending on parameters.